Amneal Pharmaceuticals, Inc Class A Common Stock
Price & Volume
Stats
See moreOpen | $17.98 |
Previous Close | $18.14 |
Day Range | $17.73-$18.16 |
52W Range | $8.82-$19.26 |
Market Cap | $5.7B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | 9.9% |
Gross Profit (12 Mos) | $1.2B |
Diluted EPS | $0.48 |
News
See moreYahoo Finance • 11 days ago
Amneal (AMRX) Q2 2026 Earnings Call Transcript
Yahoo Finance • 11 days ago
Amneal projects 2026 revenue of $3.1B-$3.2B while raising capex to about $150M
Yahoo Finance • 25 days ago
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
Yahoo Finance • 27 days ago
3 Reasons AMRX is Risky and 1 Stock to Buy Instead
About
CEO | Mr. Chirag K. Patel |
CFO | Mr. Anastasios G. Konidaris |
Address | 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 8,700 |